General MedicationsORAL-21Generic

ZOVIA 1/35E-21

ETHINYL ESTRADIOL; ETHYNODIOL DIACETATE

Standard Dose

0.035MG;1MG

Max Dose

Refer to approved labeling

Primary Use

Review priority: STANDARD Marketing status: Discontinued

Summary

Approval overview ZOVIA 1/35E-21 is listed in Drugs@FDA under application 072720 (ANDA).

Review priority: STANDARD Marketing status: Discontinued Active ingredient ETHINYL ESTRADIOL; ETHYNODIOL DIACETATE Form and strength TABLET;ORAL-21 - 0.035MG;1MG Sponsor WATSON PHARMS TEVA Submission history Latest submission status date: 2022-04-29 00:00:00.

Structured Monograph

Clinical summary

Approval overview ZOVIA 1/35E-21 is listed in Drugs@FDA under application 072720 (ANDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient ETHINYL ESTRADIOL; ETHYNODIOL DIACETATE Form and strength TABLET;ORAL-21 - 0.035MG;1MG Sponsor WATSON PHARMS TEVA Submission history Latest submission status date: 2022-04-29 00:00:00. Submission type: SUPPL.

Monitoring

• Marketing status: Discontinued
• Review priority: STANDARD

Interaction Notes

No interaction notes stored yet.